Sort   by:  
 Page size 
Unknownc-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated Leukemias.
Not available
S-EPMC4398615 | biostudies-literature
UnknownBosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial.
Not available
S-EPMC4979199 | biostudies-literature
TranscriptomicsRECURRENT SETBP1 MUTATIONS IN ATYPICAL CHRONIC MYELOID LEUKEMIA
RNA-Seq analysis of atypical chronic myeloid leukemia samples We sequenced leukemic mRNA from 13 Atypical Cronic Mieloid Leukemia (aCML) samples by Illumina GAIIx. Transcriptomic profiles, differentially expressed genes and pathway enrichment analysis were obtained comparing 7 SETBP1-mutated sample...
ORGANISM(S): Homo sapiens 
2012-12-07 | E-GEOD-42146 | biostudies-arrayexpress
UnknownBosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
Not available
S-EPMC5966023 | biostudies-literature
UnknownInflammatory/Immune Adverse Events in Chronic Myeloid Leukemia Patients During Treatment With Bosutinib.
Not available
S-EPMC11799592 | biostudies-literature
UnknownActivity of second-generation ALK inhibitors against crizotinib-resistant mutants in an NPM-ALK model compared to EML4-ALK.
Not available
S-EPMC4529334 | biostudies-literature
UnknownHow "precise" is precision medicine in hematology?
Not available
S-EPMC5210227 | biostudies-literature
UnknownMitochondrial Hyperactivation and Enhanced ROS Production are Involved in Toxicity Induced by Oncogenic Kinases Over-Signaling.
Not available
S-EPMC6316814 | biostudies-literature
UnknownIdentification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases.
Not available
S-EPMC3865592 | biostudies-literature
UnknownMolecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia.
Not available
S-EPMC8631780 | biostudies-literature
Sort   by:  
 Page size